protrac all silicone self adhering sheath standard
intermediate) (prosys international ltd -
protrac all silicone self adhering sheath short
intermediate) (prosys international ltd -
brimonidine 0.2% eye drops
fdc international ltd - brimonidine tartrate - eye drops - 2mg/1ml
emtriva 200mg capsules
gilead sciences international ltd - emtricitabine - capsule - 200mg
emtriva 10mgml oral solution
gilead sciences international ltd - emtricitabine - oral solution - 10mg/1ml
wound retractor, intermediate/deep
johnson & johnson medical pty ltd t/a depuy synthes - 45918 - wound retractor, intermediate/deep - a hand-held, manually-operated, surgical instrument used to separate/draw aside the margins of a full-thickness or near-full-thickness incision or injury during a surgical intervention.
bortezomib taro 3.5 mg
taro international ltd, israel - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - bortezomib is indicated for the treatment of patients with multiple myeloma.bortezomib is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
vortimal
k.s.kim international (sk- pharma) ltd., israel - voriconazole - powder for concentrate for solution for infusion - voriconazole 200 mg/vial - voriconazole - vortimal is a broad spectrum, triazole antifungal agent and is indicated as follows:- treatment of invasive aspergillosis.- treatment of candidaemia in non-neutropenic patients.- treatment of fluconazole-resistant serious invasive candida infections (including c. krusei).- treatment of serious fungal infections caused by scedosporium spp. and fusarium spp.vortimal should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections.prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients
dasatinib taro 100 mg
taro international ltd, israel - dasatinib - film coated tablets - dasatinib 100 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
dasatinib taro 140 mg
taro international ltd, israel - dasatinib - film coated tablets - dasatinib 140 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.